/Companies

Gladius Pharmaceuticals

Wilmington, US · Founded 2015 · Delaware corporation · 2 known investors

Find your way into Gladius Pharmaceuticals

Sign up to find every way you can get introduced to Gladius Pharmaceuticals

  • Your email: who you already know at Gladius Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gladius Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

MA
Michael AtkinExecutive

Investors · 2

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 2 rounds · 2015–2018

▶$3MraisedNov 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael AtkinExecutive Officer
  • Nathalie ChauretDirector
  • Larry SuttonDirector
  • Jens EcksteinDirector
  • Daniel HetuDirector
Offering amount
$3M
Amount sold
$3M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$727.8KraisedJun 2015 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael AtkinExecutive Officer, Director
Offering amount
$727.8K
Amount sold
$727.8K
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Gladius Pharmaceuticals's investors?
Gladius Pharmaceuticals's investors include BioHealth Innovation, Inc., Lumira Ventures.
How much funding has Gladius Pharmaceuticals raised?
Gladius Pharmaceuticals has disclosed $3.8M raised across 2 rounds.
Where is Gladius Pharmaceuticals headquartered?
Gladius Pharmaceuticals is headquartered in Wilmington, US.